Institute of Quality Leadership AMGA

Similar documents
Hepatitis C at W 17th St Family Practice

Monitoring Protocol for Clozapine-induced Myocarditis. Copyright 2017, CAMH

Measure Up/Pressure Down Medical Group Success

Hepatitis C Strategy. About us. What is hepatitis C?

Pain Management and Safe use of opioids in hospitals. Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN

Chronic Obstructive Learning Collaborative Sponsored by AMGA and Boehringer Ingelheim Pharmaceuticals, Inc..

Reducing Readmissions and Improving Outcomes at OhioHealth Mansfield Hospital:

STRENGTHENING THE COORDINATION, DELIVERY AND MONITORING OF HIV AND AIDS SERVICES IN MALAWI THROUGH FAITH-BASED INSTITUTIONS.

Trust Board of Directors Public. Denise Gale. For Assurance and Information NOT APPLICABLE NOT APPLICABLE NOT APPLICABLE NOT APPLICABLE

Blood Pressure Management: A Journey in Quality Improvement Phil E. Yphantides, M.D.

Monthly Campaign Webinar. May 19, 2016

RTT Exception Report

An Updated Approach to Colon Cancer Screening and Prevention

Best Practices in Managing Patients with Rheumatoid Arthritis. Summit Medical Group. Standardizing Protocols and Educating Providers

@PremierHA #AdvisorLive. Download today s slides at

Agenda. Illinois Diabetes Action Plan: What s In It for You? 10/27/2017

Edinburgh Access Practice Hepatitis C Clinic Jessie Anderson, Kim McBeth, John Budd and Rebecca Martin

Saving & Changing Lives: Ochsner s Opioid Stewardship Program

Bruce Kreter, PharmD Senior Director, Global HCV Medical Affairs Gilead Sciences, Inc.

Saskatchewan HIV Strategy: Social Network Approach

Sustaining Integrated Care: Making the Business Case for Routine HIV Screening and Care. Presenter: Malinda Boehler, MSW, LCSW 15 March 2017

How Can the EHR Help You Identify and Intervene with Patients Who Use Tobacco?

Dr. Steve Ligertwood Dr. Roderick Tukker Dr. David Wilton

Faster Cancer Treatment: Using a health target as the platform for delivering sustainable system changes

Treating Emergency Room Opioid Withdrawal with Buprenorphine

Standardizing Detection of Acute Kidney Injury in an Integrated Delivery Health System

One Palliative Care Annual Report

Successful Falls Prevention in Aged Persons Mental Health. Reducing the risk and decreasing severity of outcome

WHO Strategy and Goals for Viral Hepatitis Elimination

Kansas EMS Naloxone (Narcan) Administration

Investor Day EEMA Region Lausanne, September 29, Drago Azinovic President, Eastern Europe, Middle East & Africa Region & PMI Duty Free

Organ Donation Breakthrough Collaborative Institute of Medicine

Cork Integrated Falls Service: New ways of working in specialist, community and continuing care

Quarterly Stakeholders Meeting September 13, 2017

Collaborating to Implement Evidence-Based Medicine Tools. The St. John Sepsis Agent and the Interdisciplinary Sepsis Advisor

Potential disruption from private exchanges and narrow networks. In 2011, less than 10% of companies used High Performing Networks (narrow networks)

DMAS UPDATE ON GAP PROGRAM. Cindi B. Jones, Director, DMAS House Appropriations Committee September 18, 2017

USING TEAM AUDITS TO IMPROVE IMAGE QUALITY: Our Institution s Experience

Opportunities Created by Diagnostic HCV and HIV Nucleic Acid Tests

Status of Implementing Legislation Regarding the Eastern Band of Cherokee Indians

Welcome KATHY SCHWAB, DSA ACTION TEAM CHAIR. Compliance Coordinator, Mayo Clinic Transplant Center

Cincinnati Children s Hospital Medical Center PHO/OVPCA Constipation Initiative Monthly Report February 2018

Resource impact report: Sofosbuvir velpatasvir for treating chronic hepatitis C TA430

Transforming Hepatitis B Care in Kaiser Permanente Mid-Atlantic States Through a Registry and Coordinator Supported Pathway

Alignment Strategies at the JPS Health Network

Update on Community-based harm reduction services in Nelson Mandela Bay 25/10/2018

Poster Session HRT1317 Innovation Awards November 2013 Brisbane

IMPLEMENTING RECOVERY ORIENTED CLINICAL SERVICES IN OPIOID TREATMENT PROGRAMS PILOT UPDATE. A Clinical Quality Improvement Program

Reduction of High Risk Medications Using A Quality Initiative Perspective

Finding the missing children: Proven Strategies for Increasing Identification of HIV+ Children. October 2017

NoCVA Preventing Avoidable Readmissions Collaborative. Pre-work: Assessing Risk April 21, 2014

The Geisinger ProvenCare Experience. Heal Teach Discover Serve

Pat Quigley,PhD,MPH,ARNP,CRRN,FAAN,FAANP. Associate Director, VISN 8 Patient Safety Center Associate Chief for Nursing Service/Research

Annual Shareholders Meeting

Annual statement of progress Liver Disease Delivery Plan May 2017

The CIDRZ Experience: use of data to understand patient outcomes and guide program implementation 07 January 2010

Lessons learned in the use of digital imaging at Memorial Sloan Kettering Cancer Center

Integrating the Patient Perspective Into Value Frameworks

SFDPH Responds to Hepatitis C: Strategic Directions for and Beyond

Micro-elimination. A path to global elimination of hepatitis C. Prof Jeffrey V. Lazarus

One State s Perspective on the Management of Hepatitis C Drugs. February 27, 2015 Pavel Lavitas, PharmD, BCPS Clinical Consultant Pharmacist

HOW HEALTHY IS OUR COUNTY? 2013 COUNTY HEALTH RANKINGS & ROADMAPS

Palliative Care and IPOST Hospital Engagement Network June 5, Palliative Care

Together 2 Goal Innovator Track: Cardiovascular Disease Cohort. Call for Participation

11/2/2015. Increasing Access to Epidural Analgesia for Labor through Education: A Collaborative Endeavor. Aim Statement.

HCV ACTION EAST OF ENGLAND HEPATITIS C GOOD PRACTICE ROADSHOW, 9TH MAY 2017 SUMMARY REPORT

Illinois Diabetes Action Plan: What s In It for You?

Positive Living Conference

Hepatitis C in Massachusetts Epidemiology and Public Health Response

KENT BISHOP M.D. ProMedica Chief Experience Officer President Women s Service Line

Assessing Change with IIS. Steve Robison Oregon Immunization Program

Enhancing Patient Care: Implementing Advance Care Planning (ACP) Initiative In Singapore General Hospital (SGH)

Prevention Point Philadelphia

Getting to Zero in California: Integration of HIV Prevention and Surveillance

UT HEALTH S RESPONSE TO

Adult Immunizations. Business Health Care Group (BHCG) April 25, Cathy Edwards. Immunization Program Advisor

Hepatitis C. Request a Test. Benefits of testing in AOD services to improve treatment uptake

Palliative Care and Hospice in an Accountable Care Model. Key Strategies to a Successful Integrated Delivery System

Phase I Planning Grant Application. Issued by: Caring for Colorado Foundation. Application Deadline: July 1, 2015, 5:00 PM

Obstacles and Opportunities on Our Path Toward Eliminating Viral Hepatitis

AHP Musculoskeletal Service Redesign. Judith Reid MSc MMACP Consultant Physiotherapist in MSK NHS Ayrshire and Arran

Improving Access & Linkage to Care in Underserved Populations & Baby Boomers

Influenza Surveillance Animal and Public Health Partnership. Jennifer Koeman Director, Producer and Public Health National Pork Board

Trust Board Meeting in Public: Wednesday 11 July 2018 TB

Statit pimd Client Panel. Guy March, Product Lead, Midas+ Statit

Collaborative Approach in Managing the High Risk Diabetic Patient in a Patient Centered Medical Home

Implementation of an Interprofessional Team to Prevent Inpatient Hypoglycemic Events. September 13, 2016

APPENDIX ONE. 1 st Appointment (Non-admitted) recovery trajectories

South West Cancer Alliances Rapid Diagnostic Pathway for Lung Cancer Project Evaluation

Improving Opioid Agonist Therapies with System Change

SBIRT in SBHCs: A Model for Adolescent Substance Use Prevention

Holistic Programming Leads to Sustained Increases in IUD Use in Kenya

HIV and HCV coinfection - Barriers in Central and Eastern Europe

Publication Plan 2017

TACKLING COPD READMISSIONS. Wendy Presley RN

Colorectal Cancer- QI process and clinic success: A Case Study at Atascosa Health Center

Beneficiary and Pharmacy Outreach: Lessons Learned in Part D

National Hepatitis plan. Dr JP Mulkay Clinic of Hepatology Department of Hepato Gastro entrology

Bridging the Gap: Using Comprehensive Approaches to Manage HTN and Diabetes. Agenda 6/1/2016

Transcription:

Institute of Quality Leadership AMGA Ajay Sahajpal, MD Director Abdominal Transplant and Hepatobiliary Program Bradley Kruger, VP Operations ASLMC Laura Spurr, Director Clinical Transformation and Operations

Agenda Organization Snapshot Industry landscape Why Hepatitis C? Program Goals Operational Design Patient Outcomes Project Logistics and Lessons Summary

Organization Snapshot Aurora Health Care is one of the largest not-for-profit, integrated health care systems in the United States. Wisconsin and northern Illinois. ~1.2 million patients 15 hospitals ~175 clinics 80 pharmacies 60 laboratories Home care services 1600 physicians 800 advanced practice providers

Industry Landscape There is an ongoing transformation of the healthcare industry in anticipation of new economic models for financing healthcare. Key points organizations need to consider during this change: The need to do better with less by becoming agile around cost structures. The need for managing population health on a large scale by deploying more progressive business techniques such as outsourcing, shared services etc. The need to develop differentiated services with an increasing focus and transparency around quality measures, pricing, and managing populations at risk.

Hepatitis C Value-add for Patients and Healthcare Systems

Why Hepatitis C - National Attention

Summary of Hepatitis C 4-5 million people in the US have Hepatitis C virus infection 335,000 at risk patients at Aurora Health Care 8,000 undiagnosed patients within Aurora Health Care 37,000 undiagnosed people in WI 70% will progress to chronic Hepatitis C 20% will advance to cirrhosis

Goals of the Hepatitis C Program Develop a system-wide Hepatitis C screening program to standardize the care delivery process and improve clinical outcomes for this patient population. Better manage Hepatitis C patient population by enhancing integration of services throughout Aurora Health Care. Manage decompensated cirrhosis patients awaiting transplant using population health outreach-based care in the clinical contact center

Care Delivery and Treatment Diagnosis and Care Reduce the risk of transmission to others Early clinical evaluation and ongoing monitoring. Take measures to protect their liver from further harm Treatment New pharmacologic treatment can cure the disease 99% cure rate Simple 12 week regime Outcomes: Lower rates of liver cancer Lower rates of cirrhosis Lower rates of liver transplants Lower rates of all cause mortality Improves quality of life

Hepatitis C Operational Design to Succeed High Quality Outcomes

Importance of Operational Design Ensuring patients are connected with the right provider, at the right location, at the right time. Integrated health care requires seamless transition points Targets for Improvement: Service variation Under utilization of services

Integration of Services Primary Care Hepatology Clinical Contact Center GI Pharmacy Transplant

Operational Goals Target every patient Develop a mechanism to alert the provider if a patient met the criteria Develop easy and seamless Electronic Health Record tools to drive care to the right provider at the right time Develop decision points for the providers based on patient needs for further evaluation/treatment Target education efforts to keep patients informed and engaged in their care

Primary Care Workflow

GI and Hepatology Workflow

Benefits for the patient and organization Patient: Streamlined care path for patients Enhanced services Improved quality outcomes Reduced variation in services across specialties Organization: Improved Quality Increased Volume Patient Growth Financial

Primary Care Patient Education MA provides patient education by going over the Hepatitis C brochure.

Primary Care Alert displays for patients born between 1/1/1945-12/31/1965, who have not had a hepatitis C screening. Follow Up Order smartset linked to BPA

Hepatitis C Flagging Patients This flag will identify the patient in the system as a Hepatitis C Program Patient

Population Management-Outreach Provider determines during evaluation if additional outreach will be needed for the patient. A referral to Contact Center Nurse order is placed.

Population Management-Outreach Standard templates developed for ease and a consistency of care

Population Management-Outreach Standard templates developed for ease and a consistency of care

Hepatitis C Performance patients previously undiagnosed Hepatitis C (Performance) Positive Confirmatory Test Patients Under Treatment 400 350 368 300 250 258 200 150 100 50 0 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15

Hepatitis C financial outcomes Hepatitis C- Financial Performance (YTD Performance and Expected Return) $7,000,000 HEP C Expected Return Total Cont. Margin (Yearly) HEP C Performance-to-Date (August 2015) $6,000,000 $6,000,000 $6,000,000 $5,000,000 $5,578,866 $4,000,000 $3,719,244 $3,000,000 $2,000,000 $1,000,000 $0 2015 2016 2017

Summary Lessons Learned Project Planning

Implementation/Support Sponsor: Director Transplant Program Team: Primary Care physician and chairs Hepatology providers GI provider and chair Pharmacy Hospital administration Medical Group administration Call Center leaders Project Management Report Writer/Analytics Transplant Coordinators Information Technology

Timeline Planning 4 months Initial Pilot (24 outpatient clinics): LIVE on Dec. 14 2014 (all electronic tools) Target education and provider engagement for 140 providers and their clinical staff 3 month outcome tracking and monitoring System Wide (+100 outpatient clinics): in process Target education and provider engagement

Lessons Learned Reporting Continued education of new tools Ongoing provider communication Instilling accountability at the local level

Summary Expanded screening helps effectively manage our population New screening algorithm increases volume and streamlines care to Aurora Health Care services More efficacious treatments, shorter duration, less side effects mean better options for patients. Outcomes: More people screened and diagnosed More people linked to care and treatment More people cured of HCV Increased focus on HCV quality of care helps prepare us for the future

Questions